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Purpose of the study
Low HDL-cholesterol (HDL-C) levels are associated with
an increased risk of cardiovascular disease (CVD). The
objective of this study was to investigate the prevalence of
low HDL-C in HIV-infected patients and related factors.
Methods
Multicenter, cross-sectional study of all HIV-infected
patients on regular follow-up in five Andalusian hospitals
(southern Spain) during March–August 2007. A question-
naire about cardiovascular risk factors (CVR) and a physi-
cal exam, including anthropometric parameters and
blood pressure, were done in all cases. Recent fasting lab
data (≤3 prior months) were available in all cases, which
included lipid profile, glycaemia, CD4 cells count, and
HIV viral load. Statistical analysis: SPSS 11.0.
Summary of results
Data are from 1,072 patients, 43.8% of whom had low
HDL-C. The prevalence of low HDL-C was higher among
patients diagnosed with AIDS than those without AIDS
(47.7 vs. 41.1%; p = 0.037), those not on ART than those
who were on ART (53.4 vs. 42.5; p = 0.01), those with
detectable HIV viral load (55.2 vs. 40.2; p < 0.0001), with
CD4 cell counts ≤350 cells/μL (53.9 vs. 40.1%; p <
0.0001), smokers than no smokers (46.8 vs. 38.8%; p =
0.014), and those with hypertriglyceridemia (58.6 vs.
34.3%; p < 0.0001). For patients on ART, the prevalence
of low HDL-C was higher for those on PI than those tak-
ing NNRTI (52.1 vs. 31.4%; p < 0.0001). In the multivar-
iate analysis, the following factors remained significant:
tobacco use (OR 1.37, 95% CI 1,04–1.8; p = 0.04), hyper-
triglyceridemia (OR 2.94, 95% CI 2.2–3.8; p < 0.00001),
CD4 cells count ≤350 cells/μL (OR 1.74, 95% CI 1.2–2.3;
p < 0.0001), and detectable HIV viral load (OR 1.85, 95%
CI 1.3–2.5; p < 0.0001).
Conclusion
Immunological and virological situation, in addition to
traditional cardiovascular risk factors such as tobacco and
hypertriglyceridemia, affect HDL-C levels in HIV-infected
patients. For patients on ART, the use of PI is associated
with a higher probability of low levels of HDL-C.
Although it is not clear if the higher HDL-C levels associ-
ated with ART use are surrogates for decreased CVD risk,
this may be another reason to start ART earlier.
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